APA Citatie

Vollmer, B. L., Nair, K., Sillau, S., Corboy, J. R., Vollmer, T., & Alvarez, E. (2020). Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment. Ann Clin Transl Neurol.

Chicago Style citaat

Vollmer, Brandi L., Kavita Nair, Stefan Sillau, John R. Corboy, Timothy Vollmer, en Enrique Alvarez. "Rituximab Versus Natalizumab, Fingolimod, and Dimethyl Fumarate in Multiple Sclerosis Treatment." Ann Clin Transl Neurol 2020.

MLA citatie

Vollmer, Brandi L., et al. "Rituximab Versus Natalizumab, Fingolimod, and Dimethyl Fumarate in Multiple Sclerosis Treatment." Ann Clin Transl Neurol 2020.